Equibles does not estimate personal net worth.
Get an email with a short summary when BioStem Technologies, Inc. publishes a filing, an earnings call transcript or a press release.
Get BSEM alertsJason Mataszewski is recorded as CEO at BioStem Technologies, Inc. (BSEM). Jason Mataszewski has spoken on 3 earnings calls and 1 other investor event across 1 company, most recently for BioStem Technologies, Inc. on August 12, 2026. BioStem Technologies, Inc. is classified in the Biotechnology industry within the Healthcare sector.
“The second quarter was BioStem's first full quarter operating as a predominantly hospital-focused business.”
“The first quarter of 2026 marked a transformational period for Biostem. With the acquisition we completed in late January, we have repositioned the company from a physician office-focused business to a hospital-focused business.”
“Before we begin, I'll note that today's presentation includes forward-looking statements, and actual results may differ materially, and we refer to our filings in additional detail on our investor website at biostemtechnologies.com. At Biostem, our mission is simple, to create and deliver the most advanced wound…”
“Today, I'll focus on the progress we made through the fourth quarter and more recently as we continue to diversify the overall business.”
Biotechnology · Healthcare
CEO
